These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 342323)

  • 1. Extrapancreatic glucagons.
    Holst JJ
    Digestion; 1978; 17(2):168-90. PubMed ID: 342323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.
    Holst JJ
    Diabetologia; 1977 Apr; 13(2):159-69. PubMed ID: 856653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.
    Holst JJ
    Gastroenterology; 1983 Jun; 84(6):1602-13. PubMed ID: 6188645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
    Vaillant CR; Lund PK
    J Histochem Cytochem; 1986 Sep; 34(9):1117-21. PubMed ID: 3755450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
    Larsson LI; Moody AJ
    J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-related peptides in the human gastrointestinal mucosa.
    Baldissera FG; Holst JJ
    Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of glucagon in the gastrointestinal tract.
    Sasaki H; Rubalcava B; Baetens D; Blazquez E; Srikant CB; Orci L; Unger RH
    J Clin Invest; 1975 Jul; 56(1):135-45. PubMed ID: 237936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
    Morita S; Doi K; Yip CC; Vranic M
    Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study.
    Larsson LI; Holst J; Håkanson R; Sundler F
    Histochemistry; 1975 Sep; 44(4):281-90. PubMed ID: 1102501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut endocrinology: correlation of physiology and morphology.
    Polak JM; Bloom SR; Pearse AG
    Clin Endocrinol (Oxf); 1976; 5 Suppl():205S-216S. PubMed ID: 81114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical localization of glucagonlike and gastric inhibitory polypeptidelike peptides in the pancreatic islets and gastrointestinal tract.
    Smith PH
    Am J Anat; 1983 Sep; 168(1):109-18. PubMed ID: 6356867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescent localization of enteroglucagon cells in the gastrointestinal tract of the dog.
    Polak JM; Bloom S; Coulling I; Pearse AG
    Gut; 1971 Apr; 12(4):311-8. PubMed ID: 4930155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glicentin immunoreactive cells: their relationship to glucagon-producing cells.
    Ravazzola M; Siperstein A; Moody AJ; Sundby F; Jacobsen H; Orci L
    Endocrinology; 1979 Aug; 105(2):499-508. PubMed ID: 378654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of antisera to des Asn28 Thr29 Homoser27-glucagon; the development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma.
    Nishino T; Kodaira T; Shin S; Imagawa K; Yanaihara N; Shima K; Kumahara Y
    Endocrinol Jpn; 1981 Aug; 28(4):419-27. PubMed ID: 6897834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
    Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
    Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.
    Imagawa K; Nishino T; Shin S; Uehata S; Hashimura E; Yanaihara C; Yanaihara N
    Endocrinol Jpn; 1979 Feb; 26(1):123-31. PubMed ID: 86440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric inhibitory peptide-like immunoreactivity in glucagon and glicentin cells: properties and origin. An immunocytochemical study using several antisera.
    Sjölund K; Ekelund M; Håkanson R; Moody AJ; Sundler F
    J Histochem Cytochem; 1983 Jun; 31(6):811-7. PubMed ID: 6188783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.
    Doi K; Prentki M; Yip C; Muller WA; Jeanrenaud B; Vranic M
    J Clin Invest; 1979 Mar; 63(3):525-31. PubMed ID: 429572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.